Results 61 to 70 of about 112,931 (195)
High Levels of CXCL8 and Low Levels of CXCL9 and CXCL10 in Women with Maternal RhD Alloimmunization
Maternal RhD alloimmunization is an inflammatory response against protein antigens in fetal red blood cells (RBC). However, not all women become alloimmunized when exposed to RhD+ fetal RBC.
Juliana Araújo de Carvalho Schettini +8 more
doaj +1 more source
The Diagnosis and Prenatal Management of Non‐RHD Alloimmunizations
ABSTRACT Red blood cell (RBC) alloimmunization remains a relevant cause of hemolytic disease of the fetus and newborn (HDFN). Although RhD immunization has significantly decreased since the implementation of systematic prophylaxis, it is still the main cause of alloimmunization in pregnancy.
Mar Bennasar, Antoni Borrell
wiley +1 more source
Fetal RhD genotyping from maternal plasma
The prenatal diagnosis of fetal rhesus D (RhD) status is useful for the management of RhD-negative women with partners heterozygous for the RHD gene. Conventional methods for prenatal fetal RhD status determination involve invasive procedures such as fetal blood sampling and amniocentesis.
openaire +2 more sources
Identification of rare blood group donors from biobank data
Safe blood transfusion requires compatibility between recipient antibodies and donor red blood cell antigens, posing challenges for patients with rare blood group phenotypes, particularly those who are alloimmunized. Traditional identification of rare donors relies on targeted screening and labour‐intensive laboratory methods, often limited by ...
Inna Sareneva +8 more
wiley +1 more source
Summary As splicing has been shown to be commonly altered by single nucleotide variants (SNVs) in the RHD gene, resulting in a mild to severe drop in the expression of the D antigen, we sought to identify prospectively those deleterious SNVs that may disrupt splicing. All potential substitutions affecting the coding deoxyribonucleic acid (DNA) sequence
Yann Fichou +8 more
wiley +1 more source
Understanding extracellular vesicles in antiaging
Abstract Background Aging is a multifactorial process marked by gradual cellular dysregulation, regulated by hallmarks, including genomic instability, mitochondrial dysregulation, and chronic inflammation. Extracellular vesicles (EVs), especially exosomes, have emerged as pivotal mediators of cell‐to‐cell communication with potential roles in both ...
Paras Ahmad +3 more
wiley +1 more source
Fetal RHD Screening in RH1 Negative Pregnant Women: Experience in Switzerland
RH1 incompatibility between mother and fetus can cause hemolytic disease of the fetus and newborn. In Switzerland, fetal RHD genotyping from maternal blood has been recommended from gestational age 18 onwards since the year 2020.
Bernd Schimanski +11 more
doaj +1 more source
CHARACTERIZATION OF RHD*D WEAK TYPE 15 PHENOTYPE IN A JAPANESE PREGANT WOMAN – CASE REPORT
Aim: We describe a case of an obstetric patient, asian, whose Red Blood Cells (RBCs) showed a low expression of the RH:1 antigen in the routine tests and the strategies used for the characterization of an unusual RHD variant.
MG Aravechia +6 more
doaj +1 more source
Abstract Objective This study aimed to analyse the distribution and demand patterns of antigen‐negative red blood cells (RBCs) in Shandong Province, China (2022–2024), with a focus on ABO blood groups and clinically significant antigens. The research was designed to provide rigorous data for advancing precision transfusion protocols and to establish a ...
Aiping Zhao +7 more
wiley +1 more source
Fetal RHD genotyping after bone marrow transplantation
BACKGROUNDFetal RHD genotyping allows targeted diagnostic testing, fetal surveillance, and eventually intrauterine treatment to D‐alloimmunized pregnant women who carry an RHD+ fetus. However, false‐positive and false‐negative results of noninvasive prenatal fetal RHD genotyping have been described due to a variety of causes.
Thurik, Florentine F. +8 more
openaire +4 more sources

